Shanghai Kehua Bio-Engineering Co.,Ltd (SHE:002022)

China flag China · Delayed Price · Currency is CNY
5.52
-0.01 (-0.18%)
Apr 25, 2025, 3:04 PM CST
-19.88%
Market Cap 2.77B
Revenue (ttm) 1.87B
Net Income (ttm) -336.20M
Shares Out 501.63M
EPS (ttm) -0.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,117,201
Average Volume 6,191,464
Open 5.49
Previous Close 5.53
Day's Range 5.49 - 5.58
52-Week Range 4.88 - 7.86
Beta 0.58
RSI 46.78
Earnings Date Apr 28, 2025

About SHE:002022

Shanghai Kehua Bio-Engineering Co.,Ltd researches and develops, produces, and sells in vitro diagnostic reagents, medical testing equipment and other products in China and internationally. It offers signature products, including immunoassay & clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management, and automated comprehensive solutions for nucleic acid blood screening; automatic modular and clinical chemistry analyzer; automatic chemiluminescence immunoassay analyzers; and CLIA reagents tests. The c... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1981
Employees 2,151
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002022
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.